Literature DB >> 26365182

Off-Target V(D)J Recombination Drives Lymphomagenesis and Is Escalated by Loss of the Rag2 C Terminus.

Martina Mijušković1, Yi-Fan Chou2, Vered Gigi3, Cory R Lindsay4, Olga Shestova5, Susanna M Lewis6, David B Roth7.   

Abstract

Genome-wide analysis of thymic lymphomas from Tp53(-/-) mice with wild-type or C-terminally truncated Rag2 revealed numerous off-target, RAG-mediated DNA rearrangements. A significantly higher fraction of these errors mutated known and suspected oncogenes/tumor suppressor genes than did sporadic rearrangements (p < 0.0001). This tractable mouse model recapitulates recent findings in human pre-B ALL and allows comparison of wild-type and mutant RAG2. Recurrent, RAG-mediated deletions affected Notch1, Pten, Ikzf1, Jak1, Phlda1, Trat1, and Agpat9. Rag2 truncation substantially increased the frequency of off-target V(D)J recombination. The data suggest that interactions between Rag2 and a specific chromatin modification, H3K4me3, support V(D)J recombination fidelity. Oncogenic effects of off-target rearrangements created by this highly regulated recombinase may need to be considered in design of site-specific nucleases engineered for genome modification.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26365182      PMCID: PMC5089067          DOI: 10.1016/j.celrep.2015.08.034

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  27 in total

Review 1.  Lysophospholipid acyltransferases: 1-acylglycerol-3-phosphate O-acyltransferases. From discovery to disease.

Authors:  Anil K Agarwal
Journal:  Curr Opin Lipidol       Date:  2012-08       Impact factor: 4.776

Review 2.  Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures.

Authors:  Rodrig Marculescu; Katrina Vanura; Bertrand Montpellier; Sandrine Roulland; Trang Le; Jean-Marc Navarro; Ulrich Jäger; Fraser McBlane; Bertrand Nadel
Journal:  DNA Repair (Amst)       Date:  2006-06-23

3.  Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays.

Authors:  Peter J Sabo; Michael S Kuehn; Robert Thurman; Brett E Johnson; Ericka M Johnson; Hua Cao; Man Yu; Elizabeth Rosenzweig; Jeff Goldy; Andrew Haydock; Molly Weaver; Anthony Shafer; Kristin Lee; Fidencio Neri; Richard Humbert; Michael A Singer; Todd A Richmond; Michael O Dorschner; Michael McArthur; Michael Hawrylycz; Roland D Green; Patrick A Navas; William S Noble; John A Stamatoyannopoulos
Journal:  Nat Methods       Date:  2006-07       Impact factor: 28.547

4.  An epigenetic profile of early T-cell development from multipotent progenitors to committed T-cell descendants.

Authors:  Maria Alessandra Vigano; Robert Ivanek; Piotr Balwierz; Philipp Berninger; Erik van Nimwegen; Klaus Karjalainen; Antonius Rolink
Journal:  Eur J Immunol       Date:  2014-02-01       Impact factor: 5.532

5.  Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia.

Authors:  D Bellanger; V Jacquemin; M Chopin; G Pierron; O A Bernard; J Ghysdael; M-H Stern
Journal:  Leukemia       Date:  2013-09-19       Impact factor: 11.528

6.  RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.

Authors:  Elli Papaemmanuil; Inmaculada Rapado; Yilong Li; Nicola E Potter; David C Wedge; Jose Tubio; Ludmil B Alexandrov; Peter Van Loo; Susanna L Cooke; John Marshall; Inigo Martincorena; Jonathan Hinton; Gunes Gundem; Frederik W van Delft; Serena Nik-Zainal; David R Jones; Manasa Ramakrishna; Ian Titley; Lucy Stebbings; Catherine Leroy; Andrew Menzies; John Gamble; Ben Robinson; Laura Mudie; Keiran Raine; Sarah O'Meara; Jon W Teague; Adam P Butler; Giovanni Cazzaniga; Andrea Biondi; Jan Zuna; Helena Kempski; Markus Muschen; Anthony M Ford; Michael R Stratton; Mel Greaves; Peter J Campbell
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

7.  Cryptic signals and the fidelity of V(D)J joining.

Authors:  S M Lewis; E Agard; S Suh; L Czyzyk
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

8.  The RAG2 C terminus suppresses genomic instability and lymphomagenesis.

Authors:  Ludovic Deriano; Julie Chaumeil; Marc Coussens; Asha Multani; YiFan Chou; Alexander V Alekseyenko; Sandy Chang; Jane A Skok; David B Roth
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

9.  RAG2 mutants alter DSB repair pathway choice in vivo and illuminate the nature of 'alternative NHEJ'.

Authors:  Vered Gigi; Susanna Lewis; Olga Shestova; Martina Mijušković; Ludovic Deriano; Wenzhao Meng; Eline T Luning Prak; David B Roth
Journal:  Nucleic Acids Res       Date:  2014-04-20       Impact factor: 16.971

10.  Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia.

Authors:  Elisabetta Flex; Valentina Petrangeli; Lorenzo Stella; Sabina Chiaretti; Tekla Hornakova; Laurent Knoops; Cristina Ariola; Valentina Fodale; Emmanuelle Clappier; Francesca Paoloni; Simone Martinelli; Alessandra Fragale; Massimo Sanchez; Simona Tavolaro; Monica Messina; Giovanni Cazzaniga; Andrea Camera; Giovanni Pizzolo; Assunta Tornesello; Marco Vignetti; Angela Battistini; Hélène Cavé; Bruce D Gelb; Jean-Christophe Renauld; Andrea Biondi; Stefan N Constantinescu; Robin Foà; Marco Tartaglia
Journal:  J Exp Med       Date:  2008-03-24       Impact factor: 14.307

View more
  15 in total

1.  RAG1 targeting in the genome is dominated by chromatin interactions mediated by the non-core regions of RAG1 and RAG2.

Authors:  Yaakov Maman; Grace Teng; Rashu Seth; Steven H Kleinstein; David G Schatz
Journal:  Nucleic Acids Res       Date:  2016-07-19       Impact factor: 16.971

2.  The miR-15 family reinforces the transition from proliferation to differentiation in pre-B cells.

Authors:  Silke E Lindner; Michael Lohmüller; Bianka Kotkamp; Fabian Schuler; Zeynep Knust; Andreas Villunger; Sebastian Herzog
Journal:  EMBO Rep       Date:  2017-07-13       Impact factor: 8.807

Review 3.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

4.  Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.

Authors:  Y Dong; F Liu; C Wu; S Li; X Zhao; P Zhang; J Jiao; X Yu; Y Ji; M Zhang
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

5.  The IGH locus relocalizes to a "recombination compartment" in the perinucleolar region of differentiating B-lymphocytes.

Authors:  Andrey Pichugin; Olga V Iarovaia; Alexey Gavrilov; Ilya Sklyar; Natalja Barinova; Aleksandr Barinov; Evgeny Ivashkin; Gersende Caron; Said Aoufouchi; Sergey V Razin; Thierry Fest; Marc Lipinski; Yegor S Vassetzky
Journal:  Oncotarget       Date:  2017-06-20

Review 6.  Cell cycle RNA regulons coordinating early lymphocyte development.

Authors:  Alison Galloway; Martin Turner
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-02-23       Impact factor: 9.957

7.  RAG1/2 induces genomic insertions by mobilizing DNA into RAG1/2-independent breaks.

Authors:  Philipp C Rommel; Thiago Y Oliveira; Michel C Nussenzweig; Davide F Robbiani
Journal:  J Exp Med       Date:  2017-02-08       Impact factor: 14.307

8.  RAG Recombinase as a Selective Pressure for Genome Evolution.

Authors:  D Passagem-Santos; M Bonnet; D Sobral; I Trancoso; J G Silva; V M Barreto; A Athanasiadis; J Demengeot; J B Pereira-Leal
Journal:  Genome Biol Evol       Date:  2016-12-14       Impact factor: 3.416

9.  Transcriptomes of an Array of Chicken Ovary, Intestinal, and Immune Cells and Tissues.

Authors:  Eliah G Overbey; Theros T Ng; Pietro Catini; Lisa M Griggs; Paul Stewart; Suzana Tkalcic; R David Hawkins; Yvonne Drechsler
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

10.  The Conserved ATM Kinase RAG2-S365 Phosphorylation Site Limits Cleavage Events in Individual Cells Independent of Any Repair Defect.

Authors:  Susannah L Hewitt; Jason B Wong; Ji-Hoon Lee; Mayilaadumveettil Nishana; Hongxi Chen; Marc Coussens; Suzzette M Arnal; Lili M Blumenberg; David B Roth; Tanya T Paull; Jane A Skok
Journal:  Cell Rep       Date:  2017-10-24       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.